A multivariate predictive modeling approach reveals a novel CSF peptide signature for both Alzheimer's Disease state classification and for predicting future disease progression.

To determine if a multi-analyte cerebrospinal fluid (CSF) peptide signature can be used to differentiate Alzheimer's Disease (AD) and normal aged controls (NL), and to determine if this signature can also predict progression from mild cognitive impairment (MCI) to AD, analysis of CSF samples wa...

Full description

Saved in:
Bibliographic Details
Main Authors: Daniel A Llano, Saurabh Bundela, Raksha A Mudar, Viswanath Devanarayan, Alzheimer’s Disease Neuroimaging Initiative (ADNI)
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2017-01-01
Series:PLoS ONE
Online Access:https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0182098&type=printable
Tags: Add Tag
No Tags, Be the first to tag this record!